Thrombosis News and Research

Latest Thrombosis News and Research

Stago Group completes acquisition of HemoSonics

The Stago group announced today that it has completed the acquisition of HemoSonics LLC, a company specialized in the development of innovative Point-of-Care testing solutions based in Charlottesville, VA, with facilities in Durham, NC (USA).

2 Jun 2017

Therapeutic small molecules safely prevent blood clots without excessive bleeding

It may be possible to disrupt harmful blood clots in people at risk for heart attack or stroke without increasing their risk of bleeding, according to a new study published in Nature Communications.

31 May 2017

Pulmonary thrombosis-on-a-chip enables unprecedented study of blood responses to organ-level injury

The average human pair of lungs is permeated by a network of about 164 feet of blood vessels (roughly the width of a football field), including microscopic blood capillaries, which facilitate the diffusion of oxygen into the bloodstream in exchange for carbon dioxide.

23 May 2017

Researchers develop new biomedical polymer to treat atherosclerosis

Researchers at Ben-Gurion University and the Sheba Medical Center have developed a new therapy to treat atherosclerosis and prevent heart failure with a new biomedical polymer that reduces arterial plaque and inflammation in the cardiovascular system.

22 May 2017

Early intervention provides survival benefit for NSTEMI patients

An analysis of NSTEMI patients who undergo coronary revascularization within 24 hours of hospitalization showed an increased reduction in mortality, marking the first time this difference has been demonstrated.

12 May 2017

New study reveals impact of race, gender and socioeconomic status on PCI outcomes

A first-of-its-kind study discovered that women and minorities who underwent a percutaneous coronary intervention (PCI) are at a greater risk of experiencing recurrent cardiac events within the first year after their procedure compared to Caucasian men.

12 May 2017

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

26 Apr 2017

Oral contraceptive pills have negative impact on women's quality of life, study shows

One of the most common combined oral contraceptive pills has a negative impact on women's quality of life but does not increase depressive symptoms.

18 Apr 2017

Novo Nordisk introduces new web-based portal that helps patients track their hemophilia treatment

Novo Nordisk today announced the availability of HemaGo™ XChange, a web-based portal that allows people with hemophilia to connect their circle of care to their treatment and bleed information, promoting collaboration and discussion regarding the management of their bleeding disorder.

From Novo Nordisk 13 Apr 2017

Study of interactions between chemokines pinpoints potential targets for treatment of inflammation

Signal molecules called chemokines often work in tandem to recruit specific sets of immune cells to sites of tissue damage.

7 Apr 2017

Study compares burden of adverse events in patients implanted with HeartMate 3 and Heartmate II

A six-month analysis of the pivotal MOMENTUM 3 trial found that patients implanted with the new HeartMate 3 left ventricular assist system (LVAS) had fewer adverse clotting and bleeding events than patients implanted with the control, HeartMate II LVAS.

7 Apr 2017

Expert encourages cardiologists to continue using conventional drug-eluting stents

In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.

6 Apr 2017

Researchers study risk of thrombosis and bleeding in urological surgery

The international CLUE Working Group studied the risk of thrombosis and severe haemorrhage after urological cancer operations and other forms of urological surgery.

25 Mar 2017

Patients with pulmonary embolism experience long term limitations to physical stamina

A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) -- a blood clot in the lung -- experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life.

21 Mar 2017

Researchers identify sex-based differences in utilization, safety outcomes of CDT for treatment of DVT

Deep vein thrombosis (DVT) is a serious condition that occurs when a blood clot forms in a vein, often in the deep veins of the legs, thigh or pelvis. Those clots can break loose, travel to the lungs and block blood flow, causing a pulmonary embolism.

21 Mar 2017

Genotype-guided warfarin dosing linked to reduced risk of adverse events

Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with clinically guided dosing, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.

21 Mar 2017

CT scans reveal subclinical leaflet thrombosis in patients undergoing aortic valve replacement

About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots around the valve leaflets (known as subclinical leaflet thrombosis) that reduced the motion of the valves, according to an observational study presented at the American College of Cardiology's 66th Annual Scientific Session.

20 Mar 2017

Study reveals mechanisms behind increased risk of thrombosis in patients with malignant brain tumours

Patients with malignant brain tumours have an increased risk of thrombosis. Up until now we did not understand the mechanisms behind this.

16 Mar 2017

Smoking cessation program prior to hip or knee replacement provides better surgical outcomes

Smokers who needed a hip or knee replacement experienced better surgical outcomes and fewer adverse events including hospital readmissions, surgical site infections and blood clots if they were enrolled in a smoking cessation program prior to surgery, according to preliminary new research that needs to be confirmed by larger studies.

16 Mar 2017

Researchers aim to identify biomarkers that may point to blood clot risk

Cancer is one of the hardest medical conditions to overcome, and for those who do so, the battle often does not stop at remission. Many cancers predispose patients to develop blood clots, particularly patients who are diagnosed at a late stage, which often complicates their treatment and reduces survival rates.

15 Mar 2017

Thrombosis News and Research

Latest Thrombosis News and Research

Stago Group completes acquisition of HemoSonics

Therapeutic small molecules safely prevent blood clots without excessive bleeding

Pulmonary thrombosis-on-a-chip enables unprecedented study of blood responses to organ-level injury

Researchers develop new biomedical polymer to treat atherosclerosis

Early intervention provides survival benefit for NSTEMI patients

New study reveals impact of race, gender and socioeconomic status on PCI outcomes

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Oral contraceptive pills have negative impact on women's quality of life, study shows

Novo Nordisk introduces new web-based portal that helps patients track their hemophilia treatment

Study of interactions between chemokines pinpoints potential targets for treatment of inflammation

Study compares burden of adverse events in patients implanted with HeartMate 3 and Heartmate II

Expert encourages cardiologists to continue using conventional drug-eluting stents

Researchers study risk of thrombosis and bleeding in urological surgery

Patients with pulmonary embolism experience long term limitations to physical stamina

Researchers identify sex-based differences in utilization, safety outcomes of CDT for treatment of DVT

Genotype-guided warfarin dosing linked to reduced risk of adverse events

CT scans reveal subclinical leaflet thrombosis in patients undergoing aortic valve replacement

Study reveals mechanisms behind increased risk of thrombosis in patients with malignant brain tumours

Smoking cessation program prior to hip or knee replacement provides better surgical outcomes

Researchers aim to identify biomarkers that may point to blood clot risk

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Thrombosis News and Research

Latest Thrombosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in